Comparative study between the Mitsuda test and the human leukocyte antigens in leprosy patients;Estudo comparativo entre reação de Mitsuda e antígenos leucocitários humanos em pacientes hansenianos

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 40, Issue 2, 2007, Pages 188-191

  De Souza, Fabiana Covolo ^a   Marcos, Elaine Valim Camarinha ^a   Ura, Somei ^a   Opromolla, Paula Araújo ^a   Nogueira, Maria Esther Salles ^a  

^a INSTITUTO LAURO DE SOUZA LIMA   (Brazil)

Author keywords

HLA; Leprosy; Mitsuda antigen; Mycobacterium leprae

Indexed keywords

HLA DQ1 ANTIGEN; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; LEUKOCYTE ANTIGEN;

ALLELE; ARTICLE; CHEMICAL REACTION; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC TEST; GENE ISOLATION; HUMAN; INTERMETHOD COMPARISON; LEPROSY; MAJOR CLINICAL STUDY; SKIN TEST;

MYCOBACTERIUM LEPRAE;

EID: 34250312371     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822007000200008     Document Type: Article

References (27)

1. Alves C, Vieira N, Meyer I, Alves CO, Toralles MBP, Oliveira MFSP. Antígenos de histocompatibilidade humanos e dermatologia: da pesquisa para a prática clínica. Anais Brasileiros de Dermatologia 81: 65-73, 2006.
2. Beiguelman B. A reação de Mitsuda oitenta anos depois. Hansenologia Internationalis 24:144-161, 1999.
3. Britton WJ. Leprosy 1962-1992: immunology of leprosy. Transactions of the Royal Society of Tropical Medicine and Hygiene 87:508-514, 1993.
4. Izumi S, Sugiyama K, Matsumoto Y, Ohkawa S. Analysis of the immunogenetic background of Japanese leprosy patients by the HLA system. Vox sanguinis 42: 243-247, 1982.
5. a edição, Editora Atheneu, Rio de Janeiro, 1991.
6. Lagrange PH, Abel L. Susceptibilité génétique à la lèpre chez l'homme. Acta Leprologica 10: 11-27, 1996.
7. Lastória JC, Opromolla DVA, Fleury RN, Rabermann F, Curi PR. Serial Mitsuda tests for identification of reactional tuberculoid and reactional boderline leprosy forms. International Journal of Leprosy 66: 200, 1998.
8. a edição, Centro de Estudos "Dr. Reynaldo Quagliato". Instituto Souza Lima, Bauru, p.43-46, 2000.
9. Marcos EVC, Souza FC, Ura S, Opromolla DVA. Estudo de associação entre antígenos HLA e reação hansênica tipo 1 ulcerada. Anais Brasileiros de Dermatologia 75: 283-290, 2000.
10. Memória Association International de la Lepra. In: Congresso Internacional de Leprologia 6, Madrid p.1344, 1953.
11. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 16:1215, 1988.
12. Ministério da Saúde. Secretaria de Políticas de Saúde. Guia para Utilização de Medicamentos e Imunobiológicos na área de Hanseníase. Centro de Documentação do Ministério da Saúde, Brasília, 2000.
13. Mitsuda K. On the value of a skin reaction to a suspension of leprous nodules. International Journal of Leprosy 21:347-358, 1953.
14. a edição, Centro de Estudos "Dr. Reynaldo Quagliato". Instituto Lauro de Souza Lima, Bauru, p.51-58, 2000.
15. Ottenhoff THM. Immunology of leprosy. New developments. Tropical Geographical Medicine 46: 72-80, 1994.
16. Ottenhoff THM, Converse GB, Vries RRP. HLA Antigens and Neural Reversal Reaction in Ethiopian Boderline Tuberculoid Leprosy Patients. International Journal of Leprosy 55: 261-66, 1987.
17. Ottenhoff THM, Gonzalez NM, Vries RR, ConvitJ, Van Rood JJ. Association of HLA specificity LB-E12 (MB1, DC1, MT1) with lepromatous leprosy in a Venezuelan population. Tissue antigens 24: 29, 1984.
18. Pan American Health Organization. Status of Leprosy in the Region of the Americas. Disponível em: http://www.paho.org. Acesso em 16 de fevereiro de 2007.
19. Petzel-Erler ML. Genetics of the immune response and disease susceptibility. Ciência e Cultura 51: 199-211, 1999.
20. th edition Churchil. Livingstone, Edinburg, p.49-83, 1994.
21. Ridley DS, Jopling WH. Classification of Leprosy According to Immunity. A five- group system. International Journal of Leprosy 34: 255-273, 1966.
22. Rotberg A. Some aspects of immunity on leprosy and their importance in epidemiology, pathogenesis and classification of forms of the disease. Based on 1529 lepromin-tested cases. Revista Brasileira de Leprologia 5:45-97, 1937.
23. Talhari S, Neves RG. Hansenologia. Calderaro Ltda, Manaus, 1984.
24. Van Eden W, Mehra NK, Vaidya MC, D'Amarco J, Schreuder GMTh, Van Rood JJ. HLA and sporadic tuberculoid leprosy: a population study in Maharashta, India. Tissue antigens 18: 189-194, 1981.
25. Van Eden W, Vries RR, D'Amaro J, Schreuder I, Leiker DL, Van Rood JJ. HLA-DRHLA-DR associated genetic control of the type of leprosy in a population from Surinam. Human Immunology 4: 343-350, 1982.
26. Visentainer JEL, Tsuneto LT, Serra MF, Peixoto PR, Petzel-Erler ML. Association of leprosy with HLA-DR2 in a Southern Brazilian population. Brazilian Journal of Medical and Biological Research 30: 51-59, 1997.
27. World Health Organization. Elimination of Leprosy as a Public Health Problem. Disponível em: http://www.who.int/lep/. Acesso em 16 de fevereiro de 2007.